| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.5M | +195.7% |
| R&D Expense | $37.7M | +4.0% |
| SG&A Expense | $16.2M | +11.4% |
| Operating Income | -$26.6M | +36.0% |
| Interest Expense | $100K | +0.0% |
| Income Tax | $500K | — |
| Net Income | -$26.6M | +34.6% |
| EPS (Basic) | -$0.28 | +61.1% |
| EPS (Diluted) | -$0.28 | +61.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.1M | +20.8% |
| Accounts Receivable | $5.5M | +486.9% |
| Current Assets | $37.0M | +47.1% |
| Total Assets | $42.2M | +31.1% |
| Current Liabilities | $13.5M | -1.4% |
| Total Liabilities | $15.8M | +7.4% |
| Stockholders' Equity | $26.4M | +51.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.7M | +40.3% |
| Capital Expenditures | $177K | +168.2% |
| Investing Cash Flow | $75K | +134.4% |
| Financing Cash Flow | $26.3M | +156.7% |
| Free Cash Flow | -$21.9M | +39.9% |